Craft
NanoString

NanoString

nCounter Systems Installed Base

1.09 K

Q2, 2022

Revenue

$145.1 M

FY, 2021

Market Capitalization

$669.7 M

2022-09-20

NanoString Summary

Company summary

Overview
NanoString Technologies is a provider of life science tools for translational research and molecular diagnostics. The company offers three platforms: nCounter Analysis System, that allows researchers to profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations; GeoMx Digital Spatial Profiler that enables multiplexed spatial profiling of RNA and protein targets in various sample types; and CosMx Spatial Molecular Imager that enables high-resolution imaging of RNAs or proteins directly from single cells within morphologically intact whole tissue sections.
Type
Public
Founded
2003
HQ
Seattle, WA, US | view all locations
Website
https://nanostring.com
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • Brad Gray

    Brad Gray, President and Chief Executive Officer

  • Joseph M. Beechem

    Joseph M. Beechem, Chief Scientific Officer & Senior Vice President, Research & Development

  • Thomas Bailey

    Thomas Bailey, Chief Financial Officer

  • William D. Young, Chairman of the Board

    Operating MetricsView all

    Patents (US)

    34
    8.1%

    Q2, 2022

    Scientific Collaborations

    3

    FY, 2021

    Projects Completed to Date (Technology Access Program)

    920
    53.3%

    Q2, 2022

    LocationsView all

    2 locations detected

    • Seattle, WA HQ

      United States

      530 Fairview Ave N

    • Amsterdam, NH

      Netherlands

      Paasheuvelweg 25

    NanoString Financials

    Summary financials

    Revenue (Q2, 2022)
    $32.2M
    Gross profit (Q2, 2022)
    $16.4M
    Net income (Q2, 2022)
    ($39.2M)
    Cash (Q2, 2022)
    $126.0M
    EBIT (Q2, 2022)
    ($37.1M)
    Enterprise value
    $793.9M

    Footer menu